Healthcare Roundup – Americans could begin getting Pfizer vaccine on Monday, COVID-19 antibody therapy developer AbCellera Bio prices IPO above range at $20Life Science
Healthcare Roundup – China’s coronavirus vaccine has 86% efficacy in UAE trial, Pfizer/BioNTech COVID-19 vaccine docs hacked in EuropeLife Science
Healthcare Roundup – U.K. rolls out COVID-19 vaccine to public, Stage set for ‘Vaccine Summit’ at the White HouseLife Science
Healthcare Roundup – Moderna’s COVID vaccine deal gets a boost from Canada, AbbVie’s Imbruvica shows treatment benefit in untreated chronic lymphocytic leukemiaLife Science
Healthcare Roundup – House gears up for historic vote on cannabis legalization, Moderna boosts COVID-19 vaccine deal with Israel to 6M dosesLife Science
Healthcare Roundup – U.S. could immunize one-third of population, JD Health raises $3.5B in Hong Kong IPOLife Science
Healthcare Roundup – U.K. becomes first country to authorize Pfizer-BioNTech vaccine for emergency use; Feds buy another 650K doses of Lilly COVID-19 med bamlanivimabLife Science
Healthcare Roundup – Moderna shares reverse big early gains in bout of profit-taking, FDA OKs emergency use of Roche testLife Science
Healthcare Roundup – Moderna’s COVID vaccine scheduled for FDA review, BioNTech -2% post-market following BofA downgradeLife Science
Healthcare Roundup – Sorrento Therapeutics rallies, Exelixis/Takeda’s Cabometyx Ok’d in Japan for liver cancerLife Science
Healthcare Roundup – CEO says AstraZeneca likely to run new global vaccine test, Equillium nixes plan to start late-stage trials of COVID-19 treatmentLife Science
Healthcare Roundup – AstraZeneca skids another 2% as confusion remains over vaccine, Adial Pharmaceuticals inks stock purchase agreement with Keystone CapitalLife Science
